PDL Biopharma, Inc.:企業の戦略・SWOT・財務分析

【英語タイトル】PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(SWOT20MY4125)・商品コード:SWOT20MY4125
・発行会社(調査会社):MarketLine
・発行日:2020年2月
・ページ数:41
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,550見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,100見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥55,650見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

PDL Biopharma, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

PDL Biopharma, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PDL Biopharma, Inc., (PDL or ‘the company’), formerly known as Protein Design Labs, Inc., is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada.

Scope

- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PDL Biopharma, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
PDL Biopharma, Inc.: Company Overview
PDL Biopharma, Inc.: Overview and Key Facts
PDL Biopharma, Inc.: Overview
PDL Biopharma, Inc.: Key Facts
PDL Biopharma, Inc.: Key Employees
PDL Biopharma, Inc.: Key Employee Biographies
PDL Biopharma, Inc.: Major Products and Services
PDL Biopharma, Inc.: Company History
PDL Biopharma, Inc.: Management Statement
PDL Biopharma, Inc.: Locations and Subsidiaries
PDL Biopharma, Inc.: Key Competitors
PDL Biopharma, Inc.: Company Analysis
PDL Biopharma, Inc.: Business Description
PDL Biopharma, Inc.: SWOT Analysis
PDL Biopharma, Inc.: SWOT Overview
PDL Biopharma, Inc.: Strengths
PDL Biopharma, Inc.: Weaknesses
PDL Biopharma, Inc.: Opportunities
PDL Biopharma, Inc.: Threats
PDL Biopharma, Inc.: Corporate Financial Deals Activity
PDL Biopharma, Inc.: Financial Deals Overview
PDL Biopharma, Inc.: Targets and Partners
PDL Biopharma, Inc.: Top Deals 2016 – 2020YTD*
PDL Biopharma, Inc.: Mergers and Acquisitions
PDL Biopharma, Inc.: Corporate Venturing
PDL Biopharma, Inc.: Recent Developments
PDL Biopharma, Inc.: News and Events Summary
PDL Biopharma, Inc.: Business Expansion
PDL Biopharma, Inc.: Corporate Governance
PDL Biopharma, Inc.: Financial Performance
PDL Biopharma, Inc.: Regulatory and Legal Events
PDL Biopharma, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: PDL Biopharma, Inc.: Key Facts
Table 2: PDL Biopharma, Inc.: Key Employees
Table 3: PDL Biopharma, Inc.: Company History
Table 4: PDL Biopharma, Inc.: Locations and Subsidiaries
Table 5: PDL Biopharma, Inc.: Key Competitors
Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: PDL Biopharma, Inc.: Targets and Partners
Table 10: PDL Biopharma, Inc.: Top Deals 2016 - 2020YTD*
Table 11: PDL Biopharma, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 12: PDL Biopharma, Inc.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 13: PDL Biopharma, Inc.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 14: PDL Biopharma, Inc.: News and Events Summary
Table 15: PDL Biopharma, Inc.: Business Expansion
Table 16: PDL Biopharma, Inc.: Corporate Governance
Table 17: PDL Biopharma, Inc.: Financial Performance
Table 18: PDL Biopharma, Inc.: Regulatory and Legal Events
Table 19: PDL Biopharma, Inc.: Strategy and Operations

★調査レポート[PDL Biopharma, Inc.:企業の戦略・SWOT・財務分析] (コード:SWOT20MY4125)販売に関する免責事項を必ずご確認ください。
★調査レポート[PDL Biopharma, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆